EP2026787
TABLET FORMULATION COMPRISING REPAGLINIDE AND METFORMIN
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.5.2007EP published:
25.12.2013EP application number:
07728962.7
EPO information:
European Patent Register
Max expiry date:
9.5.2027
Title:
TABLET FORMULATION COMPRISING REPAGLINIDE AND METFORMIN
Timeline
Today
10.5.2007EP application
25.12.2013EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880, Bagsværd, DK
Inventor
Name:
WADA, KoichiAddress:
Kawabe-gun, Hyogo, JP
Name:
FUJITA, HikaruAddress:
Osaka-city, Osaka-pref., JP
Name:
NAKATANI, ManabuAddress:
Kawanishi, Hyogo, JP
Name:
FRIEDL, ThomasAddress:
Ochsenhausen, DE
Priority
Number:
06009902Date:
13.5.2006Country:
EP
Number:
06121953Date:
9.10.2006Country:
EP
Classification
Categories:
A61K 31/155, A61K 31/451, A61K 9/16, A61K 9/26, A61P 3/10